As of October 2023 Alnylam Pharmaceuticals has a market cap of $22.13 Billion. This makes Alnylam Pharmaceuticals the world's 773th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $22.13 B | -24.28% |
2022 | $29.23 B | 44.16% |
2021 | $20.28 B | 34.32% |
2020 | $15.10 B | 16.87% |
2019 | $12.92 B | 75.15% |
2018 | $7.37 B | -41.45% |
2017 | $12.59 B | 292.16% |
2016 | $3.21 B | -59.89% |
2015 | $8.01 B | 6.97% |
2014 | $7.48 B | 82.71% |
2013 | $4.09 B | 327.85% |
2012 | $0.95 B | 175.09% |
2011 | $0.34 B | -16.59% |
2010 | $0.41 B | -43.36% |
2009 | $0.73 B | -28.02% |
2008 | $1.02 B | -13.62% |
2007 | $1.18 B | 49.54% |
2006 | $0.79 B | 207.77% |
2005 | $0.25 B | 78.85% |
2004 | $0.14 B |
On Sep 30th, 2023 the market cap of Alnylam Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $210.67 B | 851.65% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $136.32 B | 515.80% | ๐ซ๐ท France |
![]() Regeneron Pharmaceuticals REGN | $89.33 B | 303.56% | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | $11.30 B | -48.92% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $26.69 M | -99.88% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | $1.23 B | -94.41% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $11.43 B | -48.36% | ๐ฎ๐ฑ Israel |
![]() Arrowhead Pharmaceuticals
ARWR | $2.88 B | -86.99% | ๐บ๐ธ USA |